NEW YORK/WASHINGTON (Reuters) - A U.S. Senate panel on Wednesday launched a bipartisan probe into pharmaceutical pricing, seeking documents from four drugmakers including Valeant Pharmaceuticals and Turing Pharmaceuticals, companies embroiled in controversy over price hikes on lifesaving drugs.













Source: U.S. Senate panel probing Valeant, Turing over drug costs


David Cottle

UBB Owner & Administrator